SEC Form 4/A · accession 0001185185-15-001229
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Richard K Prins
Director
Period of report
Oct 16, 2014
Accepted (ET)
May 13, 2015 · 8:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 7, 2014 | G | 1,000 | $0.00 | D | 313,000 | D |
Table II — derivative securities
No Table II lines on this filing.